C57BL/6JCya-Jag1em1/Cya
Common Name:
Jag1-KO
Product ID:
S-KO-02724
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Jag1-KO
Strain ID
KOCMP-16449-Jag1-B6J-VA
Gene Name
Product ID
S-KO-02724
Gene Alias
ABE2; Gena228; Gsfabe2; Htu; Ozz; Ser-1
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
2
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Jag1em1/Cya mice (Catalog S-KO-02724) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000028735
NCBI RefSeq
NM_013822
Target Region
Exon 4~5
Size of Effective Region
~3.1 kb
Detailed Document
Overview of Gene Research
Jag1, also known as Jagged1, is one of the 5 cell surface ligands functioning primarily in the highly conserved Notch signaling pathway. This pathway plays a critical role in cellular fate determination, being active throughout development and across many organ systems [2]. The classic Jag1-NOTCH interaction triggers a cascade of proteolytic cleavages, leading to the activation of downstream transcription of target genes.
In mouse models, EC-specific genetic deletion of Jag1 (Jag1ECKO) showed that Jag1 promotes atherosclerosis at sites of disturbed blood flow, as it suppresses subsets of endothelial cells (ECs) that proliferate and migrate [1]. In Jag1Ndr/Ndr mice, a model for Alagille syndrome (ALGS), there are immature hepatocytes, low intrahepatic T cell infiltration, and altered liver fibrosis, indicating that Jag1-dependent hepatic and immune defects interact to determine the fibrotic process in ALGS [3]. Conditional knockout and knockin of Hoxa5 in mouse kidney proximal tubules demonstrated that HOXA5 represses Jag1 transcription, affecting kidney fibrosis [4].
In conclusion, Jag1 is crucial in the Notch signaling pathway, influencing cellular fate determination. Gene-knockout mouse models have revealed its role in diseases like atherosclerosis, Alagille syndrome, and kidney fibrosis. These findings enhance our understanding of disease mechanisms related to Jag1, potentially guiding future therapeutic strategies.
References:
1. Souilhol, Celine, Tardajos Ayllon, Blanca, Li, Xiuying, Serbanovic-Canic, Jovana, Evans, Paul C. 2022. JAG1-NOTCH4 mechanosensing drives atherosclerosis. In Science advances, 8, eabo7958. doi:10.1126/sciadv.abo7958. https://pubmed.ncbi.nlm.nih.gov/36044575/
2. Grochowski, Christopher M, Loomes, Kathleen M, Spinner, Nancy B. 2015. Jagged1 (JAG1): Structure, expression, and disease associations. In Gene, 576, 381-4. doi:10.1016/j.gene.2015.10.065. https://pubmed.ncbi.nlm.nih.gov/26548814/
3. Mašek, Jan, Filipovic, Iva, Van Hul, Noémi, Dobeš, Jan, Andersson, Emma R. 2024. Jag1 insufficiency alters liver fibrosis via T cell and hepatocyte differentiation defects. In EMBO molecular medicine, 16, 2946-2975. doi:10.1038/s44321-024-00145-8. https://pubmed.ncbi.nlm.nih.gov/39358604/
4. Xiao, Xiao, Wang, Wei, Guo, Chunyuan, Chen, Jiankang, Dong, Zheng. 2024. Hypermethylation leads to the loss of HOXA5, resulting in JAG1 expression and NOTCH signaling contributing to kidney fibrosis. In Kidney international, 106, 98-114. doi:10.1016/j.kint.2024.02.023. https://pubmed.ncbi.nlm.nih.gov/38521405/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen